Paul D. Lira

1.6k total citations
14 papers, 1.2k citations indexed

About

Paul D. Lira is a scholar working on Molecular Biology, Oncology and Immunology. According to data from OpenAlex, Paul D. Lira has authored 14 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Immunology. Recurrent topics in Paul D. Lira's work include Immunotherapy and Immune Responses (4 papers), Chemokine receptors and signaling (4 papers) and T-cell and B-cell Immunology (4 papers). Paul D. Lira is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Chemokine receptors and signaling (4 papers) and T-cell and B-cell Immunology (4 papers). Paul D. Lira collaborates with scholars based in United States, Australia and France. Paul D. Lira's co-authors include William H. Brissette, Sandra P. McCurdy, Joan Wicks, Carol Donovan, Laurent Audoly, Christopher A. Gabel, Jeffrey L. Stock, Edward D. Howard, Eileen A. Elliott and T Nakagawa and has published in prestigious journals such as Journal of Biological Chemistry, Immunity and The Journal of Immunology.

In The Last Decade

Paul D. Lira

14 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul D. Lira United States	9	449	361	324	290	153	14	1.2k
Marika Karikoski Finland	17	491 1.1×	227 0.6×	422 1.3×	373 1.3×	72 0.5×	23	1.2k
Frederico S. Regateiro Portugal	14	428 1.0×	185 0.5×	356 1.1×	270 0.9×	139 0.9×	41	1.4k
Oscar J. Cordero Spain	21	302 0.7×	166 0.5×	431 1.3×	742 2.6×	138 0.9×	49	1.4k
Alexander Sternjak Germany	7	786 1.8×	299 0.8×	161 0.5×	277 1.0×	44 0.3×	12	1.2k
Fadi Jebbawi Switzerland	11	407 0.9×	123 0.3×	209 0.6×	103 0.4×	89 0.6×	20	858
Gary P. Jamieson Australia	18	438 1.0×	542 1.5×	546 1.7×	167 0.6×	19 0.1×	31	1.3k
Valeria Quarona Italy	13	379 0.8×	564 1.6×	256 0.8×	378 1.3×	35 0.2×	16	1.0k
Guoguang Zheng China	22	611 1.4×	212 0.6×	610 1.9×	215 0.7×	175 1.1×	79	1.4k
Marie B. Snook Australia	14	418 0.9×	309 0.9×	256 0.8×	328 1.1×	23 0.2×	17	943
Glennda Smithson United States	21	839 1.9×	38 0.1×	480 1.5×	292 1.0×	99 0.6×	41	1.7k

Countries citing papers authored by Paul D. Lira

Since Specialization

Citations

This map shows the geographic impact of Paul D. Lira's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul D. Lira with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul D. Lira more than expected).

Fields of papers citing papers by Paul D. Lira

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul D. Lira. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul D. Lira. The network helps show where Paul D. Lira may publish in the future.

Co-authorship network of co-authors of Paul D. Lira

This figure shows the co-authorship network connecting the top 25 collaborators of Paul D. Lira. A scholar is included among the top collaborators of Paul D. Lira based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul D. Lira. Paul D. Lira is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ching, Keith A., Donghui Huang, Kai Wang, et al.. (2018). Abstract LB-215: Analysis of mutations associated with response to glasdegib in acute myeloid leukemia (AML) and myelodysplastic syndrome (MDS). Cancer Research. 78(13_Supplement). LB–215. 3 indexed citations

Lira, Paul D., Stephen Huang, Hengmiao Cheng, et al.. (2014). Abstract 3713: Identifying a mechanism of acquired resistance to the combined inhibition of PI3K/mTOR and MEK in colorectal carcinoma. Cancer Research. 74(19_Supplement). 3713–3713. 1 indexed citations

Jackson-Fisher, Amy, Pamela Whalen, Mark Elliott, et al.. (2014). Abstract 1958: Interrogating hedgehog pathway and smoothened inhibition by PF-04449913 in patient-derived acute myeloid leukemia models. Cancer Research. 74(19_Supplement). 1958–1958. 5 indexed citations

Huang, Donghui, Dong‐Wan Kim, Αthanasios Kotsakis, et al.. (2013). Multiplexed deep sequencing analysis of ALK kinase domain identifies resistance mutations in relapsed patients following crizotinib treatment. Genomics. 102(3). 157–162. 34 indexed citations

Fisher, Timothy S., Cris Kamperschroer, Theodore Oliphant, et al.. (2012). Targeting of 4-1BB by monoclonal antibody PF-05082566 enhances T-cell function and promotes anti-tumor activity. Cancer Immunology Immunotherapy. 61(10). 1721–1733. 110 indexed citations

Matthews, Erin, Damien Thévenin, Julia M. Rogers, et al.. (2011). Thrombopoietin receptor activation: transmembrane helix dimerization, rotation, and allosteric modulation. The FASEB Journal. 25(7). 2234–2244. 55 indexed citations

Fisher, Timothy S., Paul D. Lira, Jeffrey L. Stock, et al.. (2009). Analysis of the role of the HIF hydroxylase family members in erythropoiesis. Biochemical and Biophysical Research Communications. 388(4). 683–688. 6 indexed citations

Kath, John C., William H. Brissette, Matthew F. Brown, et al.. (2004). Potent small molecule CCR1 antagonists. Bioorganic & Medicinal Chemistry Letters. 14(9). 2169–2173. 17 indexed citations

Gladue, Ronald P., Laurie Tylaska, William H. Brissette, et al.. (2003). CP-481,715, a Potent and Selective CCR1 Antagonist with Potential Therapeutic Implications for Inflammatory Diseases. Journal of Biological Chemistry. 278(42). 40473–40480. 59 indexed citations

10.

Donovan, Carol, Sandra P. McCurdy, Paul D. Lira, et al.. (2002). Absence of the P2X7 Receptor Alters Leukocyte Function and Attenuates an Inflammatory Response. The Journal of Immunology. 168(12). 6436–6445. 426 indexed citations

11.

Boyd, James G., Ronald P. Gladue, Timothy Paradis, et al.. (2001). Genomic Organization of the CC Chemokine MIP-3α/CCL20/LARC/EXODUS/SCYA20, Showing Gene Structure, Splice Variants, and Chromosome Localization. Genomics. 73(1). 28–37. 38 indexed citations

12.

Nakagawa, T, William H. Brissette, Paul D. Lira, et al.. (1999). Impaired Invariant Chain Degradation and Antigen Presentation and Diminished Collagen-Induced Arthritis in Cathepsin S Null Mice. Immunity. 10(2). 207–217. 352 indexed citations

13.

Guan, Ping, Arthur H.M. Burghes, Anne C. Cunningham, et al.. (1999). Genomic Organization and Biological Characterization of the Novel Human CC Chemokine DC-CK-1/PARC/MIP-4/SCYA18. Genomics. 56(3). 296–302. 45 indexed citations

14.

Hoppe, Craig A., et al.. (1987). [30] Nondegradable carbohydrate ligands. Methods in enzymology on CD-ROM/Methods in enzymology. 138. 404–409. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact